Center for Substance Abuse Prevention; Notice of Meeting, 10043-10044 [E6-2761]

Download as PDF wwhite on PROD1PC65 with NOTICES Federal Register / Vol. 71, No. 39 / Tuesday, February 28, 2006 / Notices Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: Primate Behavior. Date: March 20, 2006. Time: 11 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Maribeth Champoux, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3146, MSC 7759, Bethesda, MD 20892, 301–594– 3163, champoum@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Sleep Mechanisms. Date: March 20, 2006. Time: 11:30 a.m. to 1:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Richard Marcus, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5168, MSC 7844, Bethesda, MD 20892, 301–435– 1245, marcus@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: Animal Conditioning. Date: March 20, 2006. Time: 1:30 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Maribeth Champoux, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3146, MSC 7759, Bethesda, MD 20892, 301–594– 3163, champoum@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Special Emphasis Panel: Ion Channels in Cardiac Function. Date: March 20, 2006. Time: 2:30 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Maqsood A. Wani, PhD, DVM, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2114, MSC 7814, Bethesda, MD 20892, 301–435–2270, wanimaqs@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Anterior Eye Disease Member Conflict. Date: March 20, 2006. Time: 3:30 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. VerDate Aug<31>2005 17:06 Feb 27, 2006 Jkt 208001 Contact Person: Jerome Wujek, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD 20892, (301) 435– 2507, wujekjer@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Visual Bioengineering Research Projects. Date: March 21, 2006. Time: 11 a.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Jerome Wujek, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD 20892, (301) 435– 2507, wujekjer@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Hematopoiesis. Date: March 22, 2006. Time: 1:30 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Delia Tang, MD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4126, MSC 7802, Bethesda, MD 20892, (301) 435–2506, tangd@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: Sleep Apnea and Aging. Date: March 22, 2006. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Richard Marcus, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5168, MSC 7844, Bethesda, MD 20892, (301) 435– 1245, marcusr@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Minority/ Disability Predoctoral Fellowships for DCPS. Date: March 23–24, 2006. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Georgetown, 2101 Wisconsin Avenue, NW., Washington, DC 20007. Contact Person: Alfonso R. Latoni, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3022C, MSC 7770, Bethesda, MD 20892, (301) 435– 1735, latonia@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Biophysical and Biochemical Sciences. Date: March 23–24, 2006. Time: 8:30 a.m. to 5 p.m. PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 10043 Agenda: To review and evaluate grant applications. Place: Churchill Hotel, 1914 Connecticut Avenue, NW., Washington, DC 20009. Contact Person: John L. Bowers, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4178, MSC 7806, Bethesda, MD 20892, (301) 435– 1725, bowersj@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Cell Differentiation and Development. Date: March 24, 2006. Time: 10 a.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Syed Husain, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5216, MSC 7850, Bethesda, MD 20892, (301) 435– 1224, husains@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892. 93.893, National Institutes of Health, HHS) Dated: February 17, 2006. Anna Snouffer, Acting Director, Office of Federal Advisory committee Policy. [FR Doc. 06–1845 Filed 2–27–06; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given of the meeting of the Substance Abuse and Mental Health Services Administration (SAMHSA) Drug Testing Advisory Board on March 7–8, 2006. A portion of the meeting will be open and will include a roll call, general announcements, a Department of Health and Human Services drug testing program update, a Department of Transportation drug testing program update, and a Nuclear Regulatory Commission drug testing program update. Attendance by the public will be limited to space available. Public comments are welcome. Please communicate with the individual listed below as contact to make arrangements to comment or to request special accommodations for persons with disabilities. E:\FR\FM\28FEN1.SGM 28FEN1 wwhite on PROD1PC65 with NOTICES 10044 Federal Register / Vol. 71, No. 39 / Tuesday, February 28, 2006 / Notices The Board will also meet to develop the final revisions to the proposed Mandatory Guidelines for Federal Workplace Drug Testing Programs that were published in the Federal Register on April 13, 2004 (69 FR 19673) and to discuss Federal agency specimen results, confirmatory drug test issues, specimen validity test issues, laboratory inspection issues, and analytical instrumentation issues. This meeting will be conducted in closed session since discussing these issues in open session will significantly frustrate the Department’s ability to develop the revisions to the Mandatory Guidelines or to disclose information of a personal nature where disclosure would constitute an unwarranted invasion of personal privacy. The HHS Office of General Counsel made the determination that such matters are protected by exemptions (6) and 9(B) of section 552b(c) of title 5 U.S.C. and therefore may be closed to the public. To facilitate entering the building for the open session, public attendees are required to contact Mrs. Giselle Hersh, Division of Workplace Programs, 1 Choke Cherry Road, Room 2–1042, Rockville, MD 20857, 240–276–2605 (telephone) or by e-mail to Giselle.Hersh@samhsa.hhs.gov. Substantive program information and a roster of Board members may be obtained by accessing the SAMHSA workplace Web site (https:// workplace.samhsa.gov) or communicating with the contact whose name and telephone number are listed below. The transcript for the open session will be available on the SAMHSA workplace Web site as soon as possible after the meeting. Committee Name: Substance Abuse and Mental Health Services Administration Drug Testing Advisory Board. Meeting Date: March 7–8, 2006. Place: SAMHSA Building, Sugarloaf Room, 1 Choke Cherry Road, Rockville, Maryland 20850. Type: Open: March 7, 2006; 8:30 a.m.–11:30 a.m., Closed: March 7, 2006; 11:30 a.m.–4:30 p.m., Closed: March 8, 2006; 8:30 a.m.–Noon. Contact: Donna M. Bush, Ph.D., Executive Secretary, 1 Choke Cherry Road, Room 2–1033, Rockville, Maryland 20857, 240–276–2600 (telephone) and 240–276–2610 (fax), Email: Donna.Bush@samhsa.hhs.gov. VerDate Aug<31>2005 17:06 Feb 27, 2006 Jkt 208001 Dated: February 20, 2006. Toian Vaughn, Committee Management Officer, Substance Abuse and Mental Health Services Administration. [FR Doc. E6–2761 Filed 2–27–06; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HOMELAND SECURITY Immigration and Customs Enforcement Agency Information Collection Activities: Extension of a Currently Approved Information Collection; Comment Request 60-Day Notice of Information Collection under Review; Exemption from NSEERS Registration Requirements (File No. OMB–40); OMB Control Number 1653–0035. ACTION: The Department of Homeland Security, U.S. Immigration and Customs Enforcement has submitted the following information collection request for review and clearance in accordance with the Paperwork Reduction Act of 1995. The information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted for sixty days until May 1, 2006. Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the Department of Homeland Security (DHS), USCIS, Director, Regulatory Management Division, Clearance Office, 111 Massachusetts Avenue, 3rd floor, Washington, DC 20529. Comments may also be submitted to DHS via facsimile to 202–272–8352 or via e-mail at rfs.regs@dhs.gov. When submitting comments by e-mail please make sure to add OMB Control Number 1653–0035 in the subject box. Written comments and suggestions from the public and affected agencies should address one or more of the following four points: (1) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Enhance the quality, utility, and clarity of the information to be collected; and PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 (4) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of this information collection: (1) Type of Information Collection: Extention of a currently approved collection. (2) Title of the Form/Collection: Exemption from NSEERS Registration Requirements. (3) Agency form number, if any, and the applicable component of the Department of Homeland Security sponsoring the collection: No Agency Form Number (File No. OMB–40). U.S. Immigration and Customs Enforcement. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Individuals and Households. This information collection allows an alien to seek an exemption from the NSEERS registration requirements by submitting a letter to the Department of Homeland Security containing specific information. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: 5,800 responses at 30 minutes (.5 hours) per response. (6) An estimate of the total public burden (in hours) associated with the collection: 2,900 annual burden hours. If you have additional comments, suggestions, or need a copy of the proposed information collection instrument with instructions, or additional information, please contact: USCIS, Regulatory Management Division, 111 Massachusetts Avenue, 3rd Floor, Washington, DC 20529, (202) 272–8377. Dated: February 22, 2006. Richard A. Sloan, Director, Regulatory Management Division, U.S. Citizenship and Immigration Services, Department of Homeland Security. [FR Doc. E6–2743 Filed 2–27–06; 8:45 am] BILLING CODE 4410–10–P E:\FR\FM\28FEN1.SGM 28FEN1

Agencies

[Federal Register Volume 71, Number 39 (Tuesday, February 28, 2006)]
[Notices]
[Pages 10043-10044]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-2761]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given of the 
meeting of the Substance Abuse and Mental Health Services 
Administration (SAMHSA) Drug Testing Advisory Board on March 7-8, 2006.
    A portion of the meeting will be open and will include a roll call, 
general announcements, a Department of Health and Human Services drug 
testing program update, a Department of Transportation drug testing 
program update, and a Nuclear Regulatory Commission drug testing 
program update.
    Attendance by the public will be limited to space available. Public 
comments are welcome. Please communicate with the individual listed 
below as contact to make arrangements to comment or to request special 
accommodations for persons with disabilities.

[[Page 10044]]

    The Board will also meet to develop the final revisions to the 
proposed Mandatory Guidelines for Federal Workplace Drug Testing 
Programs that were published in the Federal Register on April 13, 2004 
(69 FR 19673) and to discuss Federal agency specimen results, 
confirmatory drug test issues, specimen validity test issues, 
laboratory inspection issues, and analytical instrumentation issues. 
This meeting will be conducted in closed session since discussing these 
issues in open session will significantly frustrate the Department's 
ability to develop the revisions to the Mandatory Guidelines or to 
disclose information of a personal nature where disclosure would 
constitute an unwarranted invasion of personal privacy. The HHS Office 
of General Counsel made the determination that such matters are 
protected by exemptions (6) and 9(B) of section 552b(c) of title 5 
U.S.C. and therefore may be closed to the public.
    To facilitate entering the building for the open session, public 
attendees are required to contact Mrs. Giselle Hersh, Division of 
Workplace Programs, 1 Choke Cherry Road, Room 2-1042, Rockville, MD 
20857, 240-276-2605 (telephone) or by e-mail to 
Giselle.Hersh@samhsa.hhs.gov.
    Substantive program information and a roster of Board members may 
be obtained by accessing the SAMHSA workplace Web site (https://
workplace.samhsa.gov) or communicating with the contact whose name and 
telephone number are listed below. The transcript for the open session 
will be available on the SAMHSA workplace Web site as soon as possible 
after the meeting.
    Committee Name: Substance Abuse and Mental Health Services 
Administration Drug Testing Advisory Board.
    Meeting Date: March 7-8, 2006.
    Place: SAMHSA Building, Sugarloaf Room, 1 Choke Cherry Road, 
Rockville, Maryland 20850.
    Type: Open: March 7, 2006; 8:30 a.m.-11:30 a.m., Closed: March 7, 
2006; 11:30 a.m.-4:30 p.m., Closed: March 8, 2006; 8:30 a.m.-Noon.
    Contact: Donna M. Bush, Ph.D., Executive Secretary, 1 Choke Cherry 
Road, Room 2-1033, Rockville, Maryland 20857, 240-276-2600 (telephone) 
and 240-276-2610 (fax), E-mail: Donna.Bush@samhsa.hhs.gov.

    Dated: February 20, 2006.
Toian Vaughn,
Committee Management Officer, Substance Abuse and Mental Health 
Services Administration.
[FR Doc. E6-2761 Filed 2-27-06; 8:45 am]
BILLING CODE 4162-20-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.